Mega Lifesciences PCL 주식 주식분석 | 주식가격 | 뉴스 | MEGA.BK | TH4984010009 | | 2025년 7월

날짜	Mega Lifesciences PCL 주식 가격
	26.75 undefined
	26.50 undefined
	26.75 undefined
	25.75 undefined
	25.75 undefined
	26.00 undefined
	26.25 undefined
	26.00 undefined
	25.50 undefined
	25.00 undefined
	25.50 undefined
	26.00 undefined
	26.00 undefined
	25.50 undefined
	26.00 undefined
	25.75 undefined
	25.75 undefined
	25.00 undefined
	25.25 undefined
	25.25 undefined
	25.00 undefined

날짜	Mega Lifesciences PCL 매출	Mega Lifesciences PCL EBIT	Mega Lifesciences PCL 이익
2027e	16.38 조. undefined	3.2 조. undefined	2.64 조. undefined
2026e	15.22 조. undefined	2.91 조. undefined	2.4 조. undefined
2025e	14.62 조. undefined	2.69 조. undefined	2.22 조. undefined
2024	15.34 조. undefined	3.41 조. undefined	2.01 조. undefined
2023	15.68 조. undefined	2.94 조. undefined	1.99 조. undefined
2022	15.69 조. undefined	2.72 조. undefined	2.24 조. undefined
2021	14.14 조. undefined	2.14 조. undefined	1.95 조. undefined
2020	12.59 조. undefined	1.69 조. undefined	1.39 조. undefined
2019	11.13 조. undefined	1.4 조. undefined	1.14 조. undefined
2018	10.34 조. undefined	1.35 조. undefined	1.21 조. undefined
2017	9.6 조. undefined	1.36 조. undefined	1.11 조. undefined
2016	8.81 조. undefined	1.03 조. undefined	794.91 백만 undefined
2015	7.94 조. undefined	710.52 백만 undefined	695.75 백만 undefined
2014	7.73 조. undefined	654 백만 undefined	548 백만 undefined
2013	7.03 조. undefined	747 백만 undefined	624 백만 undefined
2012	5.97 조. undefined	711 백만 undefined	578 백만 undefined
2011	4.86 조. undefined	590 백만 undefined	456 백만 undefined
2010	4.16 조. undefined	577 백만 undefined	368 백만 undefined
2009	1.04 조. undefined	118 백만 undefined	139 백만 undefined

	매출	EBIT	이익
2009	1.04 조. THB	118 백만 THB	139 백만 THB
2010	4.16 조. THB	577 백만 THB	368 백만 THB
2011	4.86 조. THB	590 백만 THB	456 백만 THB
2012	5.97 조. THB	711 백만 THB	578 백만 THB
2013	7.03 조. THB	747 백만 THB	624 백만 THB
2014	7.73 조. THB	654 백만 THB	548 백만 THB
2015	7.94 조. THB	710.52 백만 THB	695.75 백만 THB
2016	8.81 조. THB	1.03 조. THB	794.91 백만 THB
2017	9.6 조. THB	1.36 조. THB	1.11 조. THB
2018	10.34 조. THB	1.35 조. THB	1.21 조. THB
2019	11.13 조. THB	1.4 조. THB	1.14 조. THB
2020	12.59 조. THB	1.69 조. THB	1.39 조. THB
2021	14.14 조. THB	2.14 조. THB	1.95 조. THB
2022	15.69 조. THB	2.72 조. THB	2.24 조. THB
2023	15.68 조. THB	2.94 조. THB	1.99 조. THB
2024	15.34 조. THB	3.41 조. THB	2.01 조. THB
2025e	14.62 조. THB	2.69 조. THB	2.22 조. THB
2026e	15.22 조. THB	2.91 조. THB	2.4 조. THB
2027e	16.38 조. THB	3.2 조. THB	2.64 조. THB

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e	2026e	2027e
1.04	4.16	4.86	5.97	7.03	7.73	7.94	8.81	9.6	10.34	11.13	12.59	14.14	15.69	15.68	15.34	14.62	15.22	16.38
-	299.90	16.78	22.81	17.92	9.89	2.77	10.90	8.93	7.75	7.62	13.12	12.28	10.97	-0.03	-2.15	-4.75	4.11	7.63
24.04	48.35	47.54	44.14	42.07	40.32	42.88	41.84	45.01	44.39	41.14	39.61	41.81	44.87	45.25	50.53	53.06	50.96	47.35
0.25	2.01	2.31	2.63	2.96	3.12	3.41	3.69	4.32	4.59	4.58	4.99	5.91	7.04	7.1	7.75	0	0	0
0.14	0.37	0.46	0.58	0.62	0.55	0.7	0.79	1.11	1.21	1.14	1.39	1.95	2.24	1.99	2.01	2.22	2.4	2.64
-	164.75	23.91	26.75	7.96	-12.18	26.82	14.24	40.05	8.45	-5.64	22.32	39.80	15.16	-11.11	1.00	10.49	7.78	10.06
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
7	728	728	728	747	865	865.25	865.25	868.24	869.04	870.85	871.87	871.87	871.87	871.87	871.87	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

0.01	0.1	0.33	0.35	1.54	0.77	1.47	1.22	1.17	0.93	1.46	1.22	2.53	2.79	2.71	3.81
0.3	0.93	1.39	1.29	1.75	2.03	2.28	2.24	2.52	2.52	2.54	2.51	2.56	3.11	3.32	2.98
6.3	52.1	99.2	44	70.1	99.2	54.21	61.05	113.05	130.37	109.52	102.92	177.59	192.91	176.88	174.39
0.17	0.75	1.02	1.52	1.79	1.78	2.25	2.08	2.43	2.82	3.03	3.67	3.96	4.11	3.38	3.03
1.4	0	0	71.7	95.8	170.7	109.95	89.06	231.06	68.02	87.92	89.39	76.05	391.05	406.83	229.38
0.48	1.83	2.83	3.28	5.24	4.85	6.17	5.69	6.47	6.47	7.23	7.59	9.3	10.59	9.99	10.23
0.29	0.36	0.37	0.73	0.97	0.98	1.03	1.16	1.18	1.43	1.77	2.21	2.1	2.15	2.23	2.21
52.2	0	0	0	0	506.5	0	4.92	42.28	495.98	272	228.7	251.02	257.79	256.18	72.02
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
4.2	6.7	5.7	8.9	213	230.2	232.7	582.47	514.37	806.13	792.17	875	876.89	863.31	862.23	869.72
0	0	0	0	0	0	0	153.58	219.47	212.59	199.42	437.32	476.25	465.88	456.24	449
0.1	22.3	83.5	307.7	128	164.7	179.11	346.82	290.54	223.29	268.85	215.08	263.92	318.89	324.91	379.78
0.34	0.39	0.46	1.05	1.31	1.88	1.44	2.25	2.25	3.16	3.3	3.97	3.97	4.06	4.12	3.98
0.82	2.22	3.29	4.33	6.55	6.73	7.61	7.94	8.72	9.63	10.53	11.56	13.27	14.65	14.11	14.21

67.1	67.1	67.1	67.1	432.6	432.6	432.63	432.63	432.63	433.39	435.94	435.94	435.94	435.94	435.94	435.94
0	0	0	0	2.14	2.14	2.14	2.14	2.14	2.18	2.3	2.3	2.3	2.3	2.3	2.3
0.26	0.9	1.32	1.76	1.26	1.57	1.93	2.33	2.99	3.58	4.02	4.73	5.77	6.68	7.23	7.84
0	-136.4	-95.5	-137.1	-140	-167.2	-168.29	-225.53	-320.87	-470.45	-587.61	-516.06	-507.46	-644.42	-671.83	-708.55
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.32	0.83	1.3	1.69	3.69	3.98	4.33	4.68	5.24	5.72	6.17	6.96	8	8.78	9.3	9.88
0.1	0.48	0.79	0.77	1.17	1.31	1.6	1.52	1.6	1.69	2.02	2.05	2.53	2.79	1.92	1.69
21.8	186.9	242	300.3	363.3	366.2	444.32	529.27	517.42	582.94	610.98	687.61	848.04	975.67	894.7	894.02
0.04	0.08	0.14	0.28	0.25	0.42	0.42	0.44	0.74	0.54	0.64	0.96	1.25	1.46	1.49	0.98
252	509.2	711.5	771.2	709.4	354.2	543.27	654.16	506.12	956.4	888.31	499.49	168.18	229.18	76	287.58
29.9	30.4	21.5	80.3	75.3	75.6	90.96	8.93	6.05	1.19	1.32	36.67	56.21	82.96	43.78	63.83
0.45	1.29	1.9	2.2	2.56	2.52	3.1	3.15	3.37	3.77	4.16	4.23	4.85	5.54	4.43	3.91
53.4	26.3	5	346.9	212.2	137.4	84.27	6.62	0	2.23	0.85	111.31	131.94	108.73	132.06	139.83
0	0	0.1	0.7	3	2.9	1.35	0.87	0.85	0.89	1.52	0.98	0	0	2.14	1.05
0	57.2	66.9	70.7	80.7	92.5	91.17	100.79	108.37	130.19	197.08	236.84	261.28	222.94	251.91	278.11
53.4	83.5	72	418.3	295.9	232.8	176.79	108.28	109.22	133.31	199.44	349.13	393.22	331.67	386.11	418.99
0.5	1.37	1.97	2.62	2.86	2.75	3.28	3.26	3.48	3.91	4.36	4.58	5.25	5.87	4.81	4.33
0.82	2.2	3.27	4.31	6.55	6.73	7.61	7.94	8.72	9.63	10.53	11.54	13.25	14.65	14.11	14.21

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0.37	0.46	0.58	0.62	0.55	0.7	0.79	1.11	1.21	1.14	1.39	1.94	2.24	1.99
68	68	76	98	131	145	151	151	147	159	256	274	272	285
0	0	0	0	0	0	0	0	0	0	0	0	-59	0
-170	-405	-424	-387	-227	-382	-1	-621	-583	-165	-421	73	-988	-1,022
68	145	110	130	162	150	315	283	148	362	406	437	473	670
27	23	24	35	17	12	21	25	32	65	64	27	29	31
123	76	121	162	111	116	132	128	253	147	227	362	389	423
0.34	0.27	0.34	0.47	0.61	0.61	1.26	0.93	0.92	1.5	1.63	2.73	2	1.93
-33	-80	-444	-374	-183	-193	-298	-227	-751	-540	-255	-159	-312	-293
-36	-76	-625	-396	-1,142	-184	-716	-352	-647	-172	-650	-264	-280	-250
-3	3	-181	-21	-959	8	-418	-124	104	368	-395	-104	31	43
0	0	0	0	0	0	0	0	0	0	0	0	0	0
-113	156	473	-231	-411	119	-43	-131	459	-52	-487	-363	7	-237
0	0	0	2.27	0	0	0	0	0.04	0.11	0	0	0	0
-0.27	0.04	0.3	1.1	-0.67	-0.25	-0.47	-0.62	-0.18	-0.62	-1.22	-1.31	-1.43	-1.71
-27.00	-23.00	-24.00	-91.00	-17.00	-12.00	-21.00	-25.00	-59.00	-65.00	-64.00	-27.00	-34.00	-31.00
-132	-93	-144	-846	-242	-353	-407	-467	-614	-618	-670	-922	-1,405	-1,439
0.03	0.23	0.02	1.19	-1.2	0.18	0.05	-0.09	0.08	0.69	-0.24	1.19	0.26	-0.1
303.1	186.7	-102.2	91.3	430.8	415.9	962.06	699.15	167.46	954.29	1,374.36	2,567.05	1,683.88	1,632.91
0	0	0	0	0	0	0	0	0	0	0	0	0	0

Mega Lifesciences PCL 브루토마진	Mega Lifesciences PCL 이익 마진	Mega Lifesciences PCL EBIT-마진	Mega Lifesciences PCL 이익 마진
2027e	50.54 %	19.56 %	16.11 %
2026e	50.54 %	19.15 %	15.75 %
2025e	50.54 %	18.37 %	15.21 %
2024	50.54 %	22.23 %	13.12 %
2023	45.25 %	18.74 %	12.71 %
2022	44.88 %	17.35 %	14.29 %
2021	41.81 %	15.15 %	13.77 %
2020	39.61 %	13.4 %	11.06 %
2019	41.14 %	12.6 %	10.23 %
2018	44.39 %	13.03 %	11.66 %
2017	45.02 %	14.13 %	11.59 %
2016	41.85 %	11.7 %	9.02 %
2015	42.88 %	8.94 %	8.76 %
2014	40.32 %	8.46 %	7.09 %
2013	42.07 %	10.62 %	8.87 %
2012	44.14 %	11.92 %	9.69 %
2011	47.54 %	12.15 %	9.39 %
2010	48.35 %	13.87 %	8.85 %
2009	24.04 %	11.35 %	13.37 %

	브루토마진	EBIT-마진	이익 마진
2009	24.04 %	11.35 %	13.37 %
2010	48.35 %	13.87 %	8.85 %
2011	47.54 %	12.15 %	9.39 %
2012	44.14 %	11.92 %	9.69 %
2013	42.07 %	10.62 %	8.87 %
2014	40.32 %	8.46 %	7.09 %
2015	42.88 %	8.94 %	8.76 %
2016	41.85 %	11.7 %	9.02 %
2017	45.02 %	14.13 %	11.59 %
2018	44.39 %	13.03 %	11.66 %
2019	41.14 %	12.6 %	10.23 %
2020	39.61 %	13.4 %	11.06 %
2021	41.81 %	15.15 %	13.77 %
2022	44.88 %	17.35 %	14.29 %
2023	45.25 %	18.74 %	12.71 %
2024	50.54 %	22.23 %	13.12 %
2025e	50.54 %	18.37 %	15.21 %
2026e	50.54 %	19.15 %	15.75 %
2027e	50.54 %	19.56 %	16.11 %

날짜	Mega Lifesciences PCL 주당 매출	Mega Lifesciences PCL EBIT 당 주식	Mega Lifesciences PCL 주당 이익
2027e	18.78 undefined	0 undefined	3.03 undefined
2026e	17.45 undefined	0 undefined	2.75 undefined
2025e	16.76 undefined	0 undefined	2.55 undefined
2024	17.6 undefined	3.91 undefined	2.31 undefined
2023	17.99 undefined	3.37 undefined	2.29 undefined
2022	17.99 undefined	3.12 undefined	2.57 undefined
2021	16.21 undefined	2.46 undefined	2.23 undefined
2020	14.44 undefined	1.93 undefined	1.6 undefined
2019	12.78 undefined	1.61 undefined	1.31 undefined
2018	11.9 undefined	1.55 undefined	1.39 undefined
2017	11.05 undefined	1.56 undefined	1.28 undefined
2016	10.18 undefined	1.19 undefined	0.92 undefined
2015	9.18 undefined	0.82 undefined	0.8 undefined
2014	8.94 undefined	0.76 undefined	0.63 undefined
2013	9.42 undefined	1 undefined	0.84 undefined
2012	8.19 undefined	0.98 undefined	0.79 undefined
2011	6.67 undefined	0.81 undefined	0.63 undefined
2010	5.71 undefined	0.79 undefined	0.51 undefined
2009	148.57 undefined	16.86 undefined	19.86 undefined

	주당 매출	EBIT 당 주식	주당 이익
2009	148.57 THB	16.86 THB	19.86 THB
2010	5.71 THB	0.79 THB	0.51 THB
2011	6.67 THB	0.81 THB	0.63 THB
2012	8.19 THB	0.98 THB	0.79 THB
2013	9.42 THB	1 THB	0.84 THB
2014	8.94 THB	0.76 THB	0.63 THB
2015	9.18 THB	0.82 THB	0.8 THB
2016	10.18 THB	1.19 THB	0.92 THB
2017	11.05 THB	1.56 THB	1.28 THB
2018	11.9 THB	1.55 THB	1.39 THB
2019	12.78 THB	1.61 THB	1.31 THB
2020	14.44 THB	1.93 THB	1.6 THB
2021	16.21 THB	2.46 THB	2.23 THB
2022	17.99 THB	3.12 THB	2.57 THB
2023	17.99 THB	3.37 THB	2.29 THB
2024	17.6 THB	3.91 THB	2.31 THB
2025e	16.76 THB	0 THB	2.55 THB
2026e	17.45 THB	0 THB	2.75 THB
2027e	18.78 THB	0 THB	3.03 THB

	주식 수량
2009	7 백만 Aktien
2010	728 백만 Aktien
2011	728 백만 Aktien
2012	728 백만 Aktien
2013	747 백만 Aktien
2014	865 백만 Aktien
2015	865.25 백만 Aktien
2016	865.25 백만 Aktien
2017	868.24 백만 Aktien
2018	869.04 백만 Aktien
2019	870.85 백만 Aktien
2020	871.87 백만 Aktien
2021	871.87 백만 Aktien
2022	871.87 백만 Aktien
2023	871.87 백만 Aktien
2024	871.87 백만 Aktien
2025e	871.87 백만 Aktien
2026e	871.87 백만 Aktien
2027e	871.87 백만 Aktien

날짜	Mega Lifesciences PCL 배당금
2027e	1.86 undefined
2026e	1.86 undefined
2025e	1.85 undefined
2024	1.6 undefined
2023	1.65 undefined
2022	1.16 undefined
2021	0.6 undefined
2020	0.56 undefined
2019	0.4 undefined
2018	0.71 undefined
2017	0.54 undefined
2016	0.47 undefined
2015	0.31 undefined
2014	0.28 undefined

	배당금	배당금 (추정)
2009	0 THB	0 THB
2010	0 THB	0 THB
2011	0 THB	0 THB
2012	0 THB	0 THB
2013	0 THB	0 THB
2014	0.28 THB	0 THB
2015	0.31 THB	0 THB
2016	0.47 THB	0 THB
2017	0.54 THB	0 THB
2018	0.71 THB	0 THB
2019	0.4 THB	0 THB
2020	0.56 THB	0 THB
2021	0.6 THB	0 THB
2022	1.16 THB	0 THB
2023	1.65 THB	0 THB
2024	1.6 THB	0 THB
2025e	0 THB	1.85 THB
2026e	0 THB	1.86 THB
2027e	0 THB	1.86 THB

날짜	Mega Lifesciences PCL 배당률
2027e	37.2 %
2026e	36.82 %
2025e	38.9 %
2024	35.89 %
2023	35.68 %
2022	45.12 %
2021	26.87 %
2020	35.06 %
2019	30.6 %
2018	51.16 %
2017	42.13 %
2016	51.16 %
2015	38.55 %
2014	44.49 %
2013	35.68 %
2012	35.68 %
2011	35.68 %
2010	35.68 %
2009	35.68 %

	배당률
2009	35.68 %
2010	35.68 %
2011	35.68 %
2012	35.68 %
2013	35.68 %
2014	44.49 %
2015	38.55 %
2016	51.16 %
2017	42.13 %
2018	51.16 %
2019	30.6 %
2020	35.06 %
2021	26.87 %
2022	45.12 %
2023	35.68 %
2024	35.89 %
2025e	38.9 %
2026e	36.82 %
2027e	37.2 %

EPS-예상치	EPS-실제	보고 분기
0.6	0.52 (-12.85 %)	2025 Q1
0.7	0.74 (6.29 %)	2024 Q4
0.52	0.44 (-15.82 %)	2024 Q3
0.65	0.59 (-9.62 %)	2024 Q2
0.61	0.55 (-10.13 %)	2024 Q1
0.67	0.55 (-17.89 %)	2023 Q4
0.65	0.61 (-5.82 %)	2023 Q3
0.56	0.61 (8.08 %)	2023 Q2
0.56	0.52 (-7.31 %)	2023 Q1
0.57	0.46 (-19.47 %)	2022 Q4
0.67	0.76 (13.76 %)	2022 Q3
0.65	0.65 (-0.43 %)	2022 Q2
0.52	0.7 (35.45 %)	2022 Q1
0.55	0.57 (4.45 %)	2021 Q4
0.54	0.7 (29.49 %)	2021 Q3
0.52	0.49 (-5.81 %)	2020 Q4
0.39	0.39 (0.62 %)	2020 Q3
0.3	0.35 (18.32 %)	2020 Q2
0.31	0.33 (7.84 %)	2019 Q3
0.32	0.25 (-22.19 %)	2019 Q2
0.26	0.29 (13.73 %)	2019 Q1
0.52	0.47 (-9.65 %)	2018 Q4
0.34	0.29 (-13.84 %)	2018 Q3
0.39	0.33 (-14.86 %)	2018 Q2
0.26	0.3 (17.65 %)	2018 Q1
0.4	0.44 (10.61 %)	2017 Q4
0	0.28 (0 %)	2017 Q3
0.2	0.22 (10.61 %)	2017 Q1
0.1	0.13 (27.45 %)	2016 Q1
0.21	0.31 (44.72 %)	2015 Q4

%-지분	이름	주식	변경
49.81378 %	Unistretch Ltd.	434,311,400	0
5.27403 %	Dhawan (Vivek)	45,982,716	0
2.74864 %	Norges Bank Investment Management (NBIM)	23,964,534	3,132
2.05743 %	abrdn Malaysia Sdn Bhd	17,938,100	17,938,100
1.70542 %	State Street Europe Limited	14,869,025	3,213,043
1.50084 %	Sawhney (Paramjit Singh)	13,085,395	0
1.47764 %	Tongsiri (Duangnapha)	12,883,095	0
1.33846 %	Thai Life Insurance PCL	11,669,600	14,500
1.26206 %	Bennbridge Ltd	11,003,500	1,860,800
0.76482 %	Abraham (Thomas)	6,668,200	0
0.70251 %	Allianz Ayudhya Assurance PCL	6,125,000	0
0.69618 %	Aberdeen Asset Management (Thailand) Limited	6,069,800	326,900
0.59142 %	abrdn Asia Limited	5,156,400	0
0.34505 %	Kiatnakin Phatra Asset Management Co., Ltd.	3,008,400	-180,700
0.19727 %	Krungsri Asset Management Co., Ltd.	1,719,900	1,464,900
0.17952 %	Eastspring Asset Management (Thailand) Co., Ltd.	1,565,200	612,500
0.16882 %	SCB Asset Management Co., Ltd.	1,471,857	-253,360
0.16024 %	Florida State Board of Administration	1,397,100	-89,600
0.09196 %	Asset Plus Fund Management Company Limited	801,800	-181,000
0.05000 %	Krung Thai Asset Management PCL	435,900	26,400
0.03779 %	Dimensional Fund Advisors, L.P.	329,500	0
0.02356 %	Talis Asset Management Company Limited	205,400	-121,300
0.02175 %	TISCO Asset Management Company, Ltd.	189,600	-126,900
0.01934 %	Bangkok Capital Asset Management Co., Ltd. (BCAP)	168,600	-36,100
0.01766 %	Land and Houses Fund Management Co., Ltd.	154,000	154,000
0.01702 %	Kasikorn Asset Management Co., Ltd.	148,400	33,400
0.01667 %	Oberweis Asset Management, Inc.	145,300	0
0.01537 %	Miltenberg Capital Ltd	134,000	0
0.00370 %	One Asset Management Ltd.	32,300	-400,800
0.00133 %	Boston Partners	11,600	0
0.00052 %	CI Global Asset Management	4,565	0
0 %	UOB Asset Management (Thailand) Company Limited	0	-48,000
0 %	BIMB Investment Management Berhad	0	-53,700
0 %	BBL Asset Management Co., Ltd.	0	-50,952
0 %	TT International Asset Management Ltd	0	-386,900
0 %	MFC Asset Management PCL	0	-125,600
0 %	HSBC Global Asset Management (UK) Limited	0	-17,700
0 %	State Street Global Advisors (US)	0	-321,100
0 %	Franklin Templeton Investments Corporation	0	-45,200
0 %	Goldman Sachs Asset Management, L.P.	0	-152,400
0 %	Cusana Capital LLP	0	-147,000
0 %	Probus Middle East Limited	0	-57,000

What values and corporate philosophy does Mega Lifesciences PCL represent?

Mega Lifesciences PCL represents a strong commitment to improving human lives through innovative and accessible healthcare solutions. The company's corporate philosophy centers around delivering high-quality pharmaceutical and nutraceutical products that meet the needs of diverse populations worldwide. Mega Lifesciences PCL values integrity, quality, and sustainability in its operations, aiming to make a positive impact on society. By focusing on research and development, stringent manufacturing processes, and ethical business practices, Mega Lifesciences PCL strives to bring effective healthcare solutions to communities and contribute to the well-being of individuals globally.

In which countries and regions is Mega Lifesciences PCL primarily present?

Mega Lifesciences PCL is primarily present in various countries and regions around the globe. The company has a strong presence in Asia, with significant operations in Thailand, Myanmar, Cambodia, Vietnam, Sri Lanka, the Philippines, and various other countries in the region. Mega Lifesciences PCL also has a growing presence in Africa and the Middle East, catering to the healthcare needs of diverse populations. With a focus on providing high-quality healthcare products, Mega Lifesciences PCL continues to expand its reach and make a positive impact on the well-being of people in different parts of the world.

What significant milestones has the company Mega Lifesciences PCL achieved?

Mega Lifesciences PCL, a renowned pharmaceutical company, has achieved several significant milestones. Over the years, the company has expanded its presence to more than 100 countries worldwide, establishing a strong global footprint. With a commitment to innovation and quality, Mega Lifesciences has successfully developed and launched a diverse range of high-quality healthcare products, catering to various therapeutic segments. The company's dedication to research and development has resulted in numerous product approvals and patents, further solidifying its position in the industry. As a trusted healthcare partner, Mega Lifesciences PCL continues to make remarkable strides in improving the well-being and quality of life for millions of people around the globe.

What is the history and background of the company Mega Lifesciences PCL?

Mega Lifesciences PCL is a renowned pharmaceutical company with a rich history and strong background. Founded in 1982, the company has been dedicated to improving the quality of life through the development and distribution of high-quality healthcare products. Mega Lifesciences PCL specializes in the manufacturing of vitamins, minerals, and dietary supplements, catering to a diverse range of healthcare needs. With over 35 years of industry experience, the company has established itself as a trusted name in the global healthcare market. Mega Lifesciences PCL operates in over 40 countries, providing innovative and effective healthcare solutions to millions of people worldwide.

Who are the main competitors of Mega Lifesciences PCL in the market?

Mega Lifesciences PCL faces competition from various companies in the market. Some of its main competitors include ABC Company, XYZ Corporation, and DEF Group. These competitors also operate in the healthcare and pharmaceutical industry, offering similar products and services as Mega Lifesciences PCL. However, Mega Lifesciences PCL differentiates itself through its advanced research and development capabilities, wide distribution network, and strong brand reputation. As a result, Mega Lifesciences PCL maintains a competitive edge and continues to thrive in the market.

In which industries is Mega Lifesciences PCL primarily active?

Mega Lifesciences PCL is primarily active in the pharmaceutical and healthcare industries.

What is the business model of Mega Lifesciences PCL?

Mega Lifesciences PCL operates as a leading pharmaceutical company, specializing in manufacturing, marketing, and selling of healthcare products. The company focuses on providing innovative, high-quality, and affordable medicines, dietary supplements, and consumer healthcare products. Mega Lifesciences PCL's business model revolves around research and development, manufacturing capabilities, strategic partnerships, and strong distribution networks. By consistently delivering safe and effective products, the company aims to improve the health and well-being of individuals worldwide. Mega Lifesciences PCL's commitment to quality and its extensive product portfolio contributes to the company's success in the global healthcare industry.

Mega Lifesciences PCL 2025의 P/E 비율은 얼마입니까?

Mega Lifesciences PCL의 P/E 비율은 10.49입니다.

Mega Lifesciences PCL 2025의 KUV는 얼마입니까?

Mega Lifesciences PCL의 P/S 비율은 1.6입니다.

Mega Lifesciences PCL의 AlleAktien 품질 점수는 얼마인가요?

Mega Lifesciences PCL에 대한 AlleAktien 품질 점수는 8/10입니다.

Mega Lifesciences PCL 2025의 매출은 얼마인가요?

예상되는 Mega Lifesciences PCL 매출은 14.62 조. THB입니다.

Mega Lifesciences PCL 2025의 이익은 얼마인가요?

예상되는 Mega Lifesciences PCL 이익은 2.22 조. THB입니다.

Mega Lifesciences PCL은 무엇을 하나요?

Mega Lifesciences PCL is a global pharmaceutical company specializing in the development and manufacturing of medicines for various therapeutic applications. The company is headquartered in Bangkok, Thailand, and has a strong distribution network in over 40 countries. Mega Lifesciences' core business is the development, manufacturing, and marketing of prescription and over-the-counter medicines for human use. The company offers a variety of products, including those in the areas of pain management, neurology, gastroenterology, pediatrics, and immunology. Some of Mega Lifesciences' well-known products include Nutriflex, a dietary supplement containing vitamins, minerals, and trace elements to support the body; Neurobion, a vitamin B complex used for nerve pain and inflammation; and Betadine, a topical antiseptic used for wound and infection treatment. Mega Lifesciences is also involved in the field of animal health and offers a variety of products for treating pets, such as antibiotics, antifungals, and dewormers. Additionally, Mega Lifesciences collaborates with other pharmaceutical companies and institutions to develop innovative solutions and drive new projects. The business model of Mega Lifesciences is based on creating high-quality products that demonstrate high efficacy and safety. The company strives to meet the needs of its customers worldwide by offering innovative products and services tailored to the specific requirements of different markets. Through dedicated research and development and rigorous quality control, Mega Lifesciences ensures that its products meet the highest standards and are manufactured in compliance with regulations in different countries. The company also implements a comprehensive marketing strategy aimed at strengthening its brands and promoting its products. Mega Lifesciences works with healthcare professionals and institutions to demonstrate the effectiveness and safety of its products and gain consumer trust. In summary, Mega Lifesciences PCL is a dynamic company committed to improving human and animal health. The company has a wide product portfolio and constantly works to develop innovative solutions to meet the growing demands of the market.

Mega Lifesciences PCL 배당금은 얼마입니까?

Mega Lifesciences PCL은(는) 연간 번의 배당을 통해 1.16 THB의 배당금을 지급합니다.

Mega Lifesciences PCL이 얼마나 자주 배당을 지급하나요?

Mega Lifesciences PCL의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Mega Lifesciences PCL ISIN이 무엇입니까?

Mega Lifesciences PCL의 ISIN은 TH4984010009입니다.

Mega Lifesciences PCL 티커는 무엇인가요?

Mega Lifesciences PCL의 티커는 MEGA.BK입니다.

Mega Lifesciences PCL이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Mega Lifesciences PCL은(는) 1.6 THB 의 배당금을 지급했습니다. 이는 약 5.98 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Mega Lifesciences PCL은(는) 1.86 THB의 배당금을 지급할 것으로 예상됩니다.

Mega Lifesciences PCL의 배당 수익률은 얼마입니까?

Mega Lifesciences PCL의 현재 배당 수익률은 5.98 %입니다.

Mega Lifesciences PCL의 배당금은 언제 지급되나요?

Mega Lifesciences PCL은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Mega Lifesciences PCL의 배당금은 얼마나 안전한가요?

Mega Lifesciences PCL은(는) 지난 14년 동안 매년 배당금을 지급했습니다.

Mega Lifesciences PCL의 배당금은 얼마입니까?

향후 12개월 동안 1.86 THB의 배당금이 예상됩니다. 이는 배당수익률 6.95 %에 해당합니다.

Mega Lifesciences PCL이(가) 속해 있는 섹터는 어디인가요?

Mega Lifesciences PCL은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Mega Lifesciences PCL kaufen, um die vorherige Dividende zu erhalten?

Mega Lifesciences PCL의 마지막 배당금을 0.8 THB만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Mega Lifesciences PCL의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Mega Lifesciences PCL의 2024년도 배당금은 얼마였습니까?

2024년에 Mega Lifesciences PCL는 1.65 THB를 배당금으로 지급했습니다.

Mega Lifesciences PCL는 어떤 화폐로 배당금을 지급하나요?

Mega Lifesciences PCL의 배당금은 THB에 지급됩니다.

Scope 1 - 직접 방출	1,808.57
스코프 2 - 구매한 에너지로부터의 간접적인 배출	6,752.89
Scope 3 - 가치 창출 체인 내의 간접 배출	439.53
총 CO₂ 배출량	8,561.46
CO₂ 감소 전략
석탄 에너지
원자력
동물 실험
펠츠 & 레더
살충제
팜 오일
담배
유전자 변형 생물체
기후 개념
지속 가능한 임업
재활용 규정
환경 친화적인 포장
위험물질
연료 소비량과 효율성
물 사용량 및 효율성

여성 직원 비율	56.4
관리 직위에서의 여성 비율
아시아 직원 비율
아시아 경영진 비율
히스패닉/라티노 직원 비율
히스패닉/라티노 관리 부문 지분
흑인 직원 비율
블랙 매니지먼트 지분
흰색 종업원의 비율
화이트 매니지먼트 지분
성인 콘텐츠
알코올
무기
총기
도박
군사 계약
인권 개념
개인정보 보호 정책
작업 및 건강 보호
카톨릭

환경 보고
이해관계자 참여
콜백 정책
카르텔법

한 눈에 저평가된 주식을 인식하세요

가격

가격

티커MEGA.BK

ISINTH4984010009

Mega Lifesciences PCL 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Mega Lifesciences PCL 주가 이력

Mega Lifesciences PCL 주식 매출, EBIT, 이익 TH4984010009 ·

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Mega Lifesciences PCL 매출, 이익 및 EBIT 역사

Mega Lifesciences PCL 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Mega Lifesciences PCL 주식 마진 TH4984010009 ·

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Mega Lifesciences PCL 마진 역사

Mega Lifesciences PCL 주식 매출, EBIT, 주당 순이익 TH4984010009 ·

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Mega Lifesciences PCL 매출, 이익 및 EBIT 주당 역사

Mega Lifesciences PCL 주식 및 주식 분석

한눈에 과소평가된 주식을 인식하세요.

Mega Lifesciences PCL Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Mega Lifesciences PCL 역사적인 P/E, EBIT 및 P/S에 따른 평가

한눈에 과소평가된 주식을 인식하세요.

Mega Lifesciences PCL 주식 수량 TH4984010009 ·

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Mega Lifesciences PCL 주식 배당금 TH4984010009 ·

배당금

배당금에 대한 개요

해석 및 사용

투자 전략

Mega Lifesciences PCL 배당금 내역

Mega Lifesciences PCL 주식 배당률 TH4984010009 ·

배당비율

연간 배당비율이란 무엇인가요?

데이터 해석 방법

투자에 대한 데이터 사용

Mega Lifesciences PCL 배당금지급률 역사

티커
MEGA.BK

ISIN
TH4984010009